Medical devices having homogeneous charge density and methods for making same
US-9170349-B2 · Oct 27, 2015 · US
US11853013B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11853013-B2 |
| Application number | US-202016901113-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 15, 2020 |
| Priority date | Jun 15, 2020 |
| Publication date | Dec 26, 2023 |
| Grant date | Dec 26, 2023 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Described are systems and methods which can be used to indicate the period of time elapsed since the occurrence of a triggering event. More particularly, this application relates to systems and methods which can be used to visually indicate the time period elapsed since an article has been removed from its packaging. The system can include an indicator disposed on or within the article and a trigger disposed within the receptacle and in contact with the indicator. The article may be enclosed within a sealable receptacle of the package. The indicator is responsive to a change in a concentration of the trigger in contact with the indicator.
Opening claim text (preview).
We claim: 1. A system for visually indicating the time elapsed since an article has been removed from a package, the system comprising: an indicator disposed on or within the article, wherein the article is enclosed within a sealable receptacle of the package; and a trigger disposed within the receptacle and in contact with the indicator; wherein the indicator is responsive to a change in a concentration of the trigger in contact with the indicator, wherein the indicator comprises a population of nanoparticles stabilized by a capping agent, and wherein the trigger comprises a solution comprising the capping agent in contact with the indicator, wherein when the article is removed from the receptacle and placed in contact with a solution containing a lower concentration of the trigger, the capping agent disassociates from the nanoparticles, thereby inducing aggregation of the population of nanoparticles; and wherein aggregation of the population of nanoparticles results in a color change. 2. The system of claim 1 , wherein the trigger is present at a static concentration within the receptacle. 3. The system of claim 1 , wherein the population of nanoparticles has an average particle size of from 5 nm to 100 nm as measured by transmission electron microscopy (TEM). 4. The system of claim 1 , wherein the population of nanoparticles has a monodisperse particle size distribution. 5. The system of claim 1 , wherein the nanoparticles have a spherical, a rod, a cone, a cylindrical, a shell, or a star shape. 6. The system of claim 1 , wherein the nanoparticles have a homogenous particle shape. 7. The system of claim 1 , wherein the nanoparticles comprise a mixture of particle shapes. 8. The system of claim 1 , wherein the capping agent is non-covalently associated with the nanoparticles. 9. The system of claim 1 , wherein the capping agent is biocompatible. 10. The system of claim 1 , wherein the article comprises a medical device. 11. The system of claim 1 , wherein the article comprises an ophthalmic device. 12. The system of claim 1 , wherein the indicator is patterned on the article. 13. The system of claim 1 , wherein the indicator is stable to autoclaving. 14. The system of claim 1 , wherein removal of the article from the receptacle induces a change in concentration of the trigger in contact with the indicator. 15. The system of claim 14 , wherein the change in the concentration of the trigger induces a change in a color of the indicator. 16. The system of claim 15 , wherein the change in color comprises a change from a first color in the visible spectrum to a second color in the visible spectrum. 17. The system of claim 15 , wherein the change in color comprises a change from a first color outside of the visible spectrum to a second color in the visible spectrum. 18. The system of claim 15 , wherein the change in color comprises a change from a first color in the visible spectrum to a second color outside of the visible spectrum. 19. The system of claim 1 , wherein the population of nanoparticles comprises a population of plasmonic nanoparticles. 20. The system of claim 19 , wherein the population of plasmonic nanoparticles comprise gold, silver, platinum, or a combination thereof. 21. The system of claim 1 , wherein the nanoparticles have a polyhedral shape. 22. The system of claim 21 , wherein the nanoparticles have a cubic shape, an octahedral shape, a decahedral shape, a cuboctahedral shape, a tetrahedral shape, a rhombic dodecahedral shape, a truncated ditetragonal prismatic shape, or a truncated bitetrahedral shape. 23. The system of claim 1 , wherein the capping agent comprises a surfactant. 24. The system of claim 23 , wherein the surfactant comprises an anionic surfactant, a cationic surfactant, a non-ionic surfactant, an amphoteric surfactant, or a combination thereof. 25. The system of claim 23 , wherein the surfactant comprises a phosphatide, a polyoxyethylene sorbitan fatty acid ester, a polyoxyethylene alkyl ether, stearic acid, benzalkonium chloride, calcium stearate, glycerol monostearate, cetostearyl alcohol, 3-[N,N-Dimethyl(3-palmitoylaminopropyl)ammonio]-propanesulfonate, N-Dodecyl-N,N-(dimethylammonio)butyrate, sodium dodecyl sulfate (SDS), sodium lauryl sulfate, octadecanoic acid, a poloxamer, a poloxamine, an alkyl aryl polyether sulfonate, palmitic acid, dodecylphosphonic acid, sodium oleate, sodium octanoate, cetyltrimethylammonium bromide, tetrabutylammonium hydroxide titrant, sodium dodecyl phosphonate, tetrabutylammonium palmitate, tetrabutylammonium laurate, a polysorbate, or a combination thereof. 26. The system of claim 1 , wherein the capping agent comprises a polymer. 27. The system of claim 26 , wherein the polymer comprises polyvinylpyrrolidone, polyvinyl alcohol, a polyalkylene oxide, a cellulosic polymer, tyloxapol, or a combination thereof. 28. The system of claim 1 , wherein the capping agent disassociates from the nanoparticles at a rate selected such that the color change indicates a predetermined period of time has elapsed since the article has been removed from the receptacle. 29. The system of claim 28 , wherein the predetermined period of time is from 30 minutes to 30 days. 30. The system of claim 1 , wherein the indicator comprises a first population of nanoparticles stabilized by a first capping agent and a second population of nanoparticles stabilized by a second capping agent, and wherein the trigger comprises a solution comprising the first capping agent and the second capping in contact with the indicator. 31. The system of claim 30 , wherein when the article is removed from the receptacle and placed in contact with a solution containing a lower concentration of the trigger, the first capping agent disassociates from first population of nanoparticles at a faster rate than the second capping agent disassociates from the second population of nanoparticles. 32. The system of claim 30 , wherein when the article is removed from the receptacle and placed in contact with a solution containing a lower concentration of the trigger, the first capping agent disassociates from the first population nanoparticles, thereby inducing aggregation of the first population of nanoparticles and generating a first color change, then the second capping agent disassociates from the second population nanoparticles, thereby inducing aggregation of the second population of nanoparticles and generating a second color change. 33. The system of claim 30 , wherein the first capping agent disassociates from the first population of nanoparticles at a first rate selected such that the first color change indicates a first predetermined period of time has elapsed since the article has been removed from the receptacle, and wherein the second capping agent disassociates from the second population nanoparticles at a second rate selected such that the second color change indicates a second predetermined period of time has elapsed since the article has been removed from the receptacle. 34. The system of claim 33 , wherein the first predetermined period of time is from 10 minutes to two weeks and wherein the second predetermined period of time is from 30 minutes to 30 days, such as from 1 hour to 30 days. 35. The syst
using optical means · CPC title
for investigating time/temperature history · CPC title
Silver; Compounds thereof · CPC title
Medicaments · CPC title
Wetness-indicators or colourants · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.